1. Home
  2. NAMSW vs OCFCP Comparison

NAMSW vs OCFCP Comparison

Compare NAMSW & OCFCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMSW
  • OCFCP
  • Stock Information
  • Founded
  • NAMSW N/A
  • OCFCP N/A
  • Country
  • NAMSW Netherlands
  • OCFCP United States
  • Employees
  • NAMSW 29
  • OCFCP 920
  • Industry
  • NAMSW Biotechnology: Pharmaceutical Preparations
  • OCFCP Major Banks
  • Sector
  • NAMSW Health Care
  • OCFCP Finance
  • Exchange
  • NAMSW Nasdaq
  • OCFCP Nasdaq
  • Market Cap
  • NAMSW N/A
  • OCFCP N/A
  • IPO Year
  • NAMSW N/A
  • OCFCP N/A
  • Fundamental
  • Price
  • NAMSW $9.00
  • OCFCP $24.98
  • Analyst Decision
  • NAMSW
  • OCFCP
  • Analyst Count
  • NAMSW 0
  • OCFCP 0
  • Target Price
  • NAMSW N/A
  • OCFCP N/A
  • AVG Volume (30 Days)
  • NAMSW N/A
  • OCFCP N/A
  • Earning Date
  • NAMSW N/A
  • OCFCP N/A
  • Dividend Yield
  • NAMSW N/A
  • OCFCP N/A
  • EPS Growth
  • NAMSW N/A
  • OCFCP N/A
  • EPS
  • NAMSW N/A
  • OCFCP N/A
  • Revenue
  • NAMSW N/A
  • OCFCP N/A
  • Revenue This Year
  • NAMSW N/A
  • OCFCP N/A
  • Revenue Next Year
  • NAMSW N/A
  • OCFCP N/A
  • P/E Ratio
  • NAMSW N/A
  • OCFCP N/A
  • Revenue Growth
  • NAMSW N/A
  • OCFCP N/A
  • 52 Week Low
  • NAMSW N/A
  • OCFCP N/A
  • 52 Week High
  • NAMSW N/A
  • OCFCP N/A
  • Technical
  • Relative Strength Index (RSI)
  • NAMSW 47.49
  • OCFCP 59.85
  • Support Level
  • NAMSW $9.40
  • OCFCP $24.69
  • Resistance Level
  • NAMSW $10.14
  • OCFCP $25.00
  • Average True Range (ATR)
  • NAMSW 0.44
  • OCFCP 0.06
  • MACD
  • NAMSW -0.12
  • OCFCP 0.01
  • Stochastic Oscillator
  • NAMSW 24.31
  • OCFCP 93.55

About NAMSW NewAmsterdam Pharma Company N.V. Warrant

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About OCFCP OceanFirst Financial Corp. Depositary Shares

OceanFirst Financial Corp is engaged in the banking sector of the United States. It conducts the business of attracting retail and business deposits and investing them in loans, consisting of single-family, owner-occupied residential mortgage loans, and commercial real estate loans. The company's sole segment deals with the delivery of loan and deposit products to customers. The bank's revenues are derived principally from interest on its loans, and to a lesser extent, interest on its investment and mortgage-backed securities. The rest of its income is dependent on bank card services and wealth management services.

Share on Social Networks: